Skip to main content

Skye Bioscience to Participate in Upcoming Investment Conferences

By: Newsfile
ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness.

San Diego, California--(Newsfile Corp. - November 24, 2025) - Skye Bioscience, Inc. (NASDAQ: SKYE) ("Skye"), a clinical-stage biotechnology company focused on unlocking new therapeutic pathways for obesity and other metabolic health disorders, will participate in the following upcoming investment conferences:

  • Citi Global Healthcare Conference (Miami)
    1x1 meetings: Dec. 2

  • Evercore Annual Healthcare Conference (Coral Gables)
    Fireside Chat: Dec. 3, 12:55 pm ET
    1x1 meetings

  • Piper Sandler Annual Healthcare Conference (New York)
    Fireside Chat: Dec. 4, 11:30 am ET
    1x1 meetings

Available webcasts will be accessible on Skye's website.

About Skye Bioscience

Skye is focused on unlocking new therapeutic pathways for metabolic health through the development of next-generation molecules that modulate G-protein coupled receptors. Skye's strategy leverages biologic targets with substantial human proof of mechanism for the development of potential first-in-class therapeutics with potential clinical and commercial differentiation. Skye is conducting a Phase 2a clinical trial (ClinicalTrials.gov: NCT06577090) in obesity for nimacimab, a negative allosteric modulating antibody that peripherally inhibits CB1. This study is also assessing the combination of nimacimab and a GLP-1R agonist (Wegovy®). For more information, please visit: www.skyebioscience.com. Connect with us on X and LinkedIn.

CONTACTS

Investor & Media Relations
ir@skyebioscience.com
(858) 410-0266

LifeSci Advisors, Mike Moyer
mmoyer@lifesciadvisors.com
(617) 308-4306

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/275680

Report this content

If you believe this article contains misleading, harmful, or spam content, please let us know.

Report this article

Recent Quotes

View More
Symbol Price Change (%)
AMZN  267.74
+9.85 (3.82%)
AAPL  352.45
+0.54 (0.15%)
AMD  530.14
+26.73 (5.31%)
BAC  48.91
-0.53 (-1.07%)
GOOG  279.20
+1.60 (0.58%)
META  616.38
-2.49 (-0.40%)
MSFT  508.29
+2.05 (0.40%)
NVDA  150.96
-4.50 (-2.89%)
ORCL  113.89
-1.11 (-0.97%)
TSLA  383.72
+3.61 (0.95%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.